We are live on !
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$156M
Turnover
90.24%
1-Year Est. Return
14.89%
This Fund
S&P 500
This Quarter Est. Return
+7.46%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.1%
AUM
$156M
AUM Growth
+$74.4M
(+91%)
Cap. Flow
+$78.8M
Cap. Flow % of AUM
Cap. Flow %
50.43%
Top 10 Holdings %
Top 10 Hldgs %
25.26%
Holding
328
New
191
Increased
20
Reduced
12
Closed
105
Avg Time Held
0
years
Top 10 Avg Time Held
0.1
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$8.52M |
| 2 |
NVIDIA
NVDA
|
+$6.41M |
| 3 |
Oracle
ORCL
|
+$5.76M |
| 4 |
Microsoft
MSFT
|
+$3.56M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$3.44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$5.33M |
| 2 |
ExxonMobil
XOM
|
+$2.87M |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.69M |
| 4 |
Rocket Lab Corp
RKLB
|
+$2.61M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$2.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.57% |
| 2 | Consumer Discretionary | 16.88% |
| 3 | Financials | 11.54% |
| 4 | Healthcare | 9.13% |
| 5 | Materials | 6.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
Tetra Tech
TTEK
$9.47B
| $200K | 0.13% |
+6,934
| New | +$203K |
2026 Q2
0 quarters
|
|
202
Vodafone
VOD
$36.5B
| $198K | 0.13% |
+15,000
| New | +$227K |
2026 Q2
0 quarters
|
|
203
Inter&Co
INTR
$3.17B
| $194K | 0.12% |
+35,664
| New | +$240K |
2026 Q2
0 quarters
|
|
204
Lyft
LYFT
$6.41B
| $186K | 0.12% |
+12,700
| New | +$178K |
2026 Q2
0 quarters
|
|
205
Aegon
AEG
$12B
| $176K | 0.11% |
+20,800
| New | +$171K |
2026 Q2
0 quarters
|
|
206
KT
KT
$8.2B
| $173K | 0.11% |
+10,000
| New | +$199K |
2026 Q2
0 quarters
|
|
207
Full Truck Alliance
YMM
$8.6B
| $169K | 0.11% |
+20,813
| New | +$177K |
2026 Q2
0 quarters
|
|
|
ORLA
208
DELISTED
Orla Mining
ORLA
| $164K | 0.11% |
+16,800
| New | +$224K |
2026 Q2
0 quarters
|
|
209
DELISTED
Leggett & Platt
LEG
| $157K | 0.1% |
+13,400
| New | +$141K |
2026 Q2
0 quarters
|
|
210
Vital Farms
VITL
$392M
| $142K | 0.09% |
+12,200
| New | +$136K |
2026 Q2
0 quarters
|
|
211
Flowers Foods
FLO
$1.3B
| $140K | 0.09% |
+17,700
| New | +$142K |
2026 Q2
0 quarters
|
|
212
Upwork
UPWK
$1.18B
| $133K | 0.09% |
15,900
+3,300
| +26% | +$31.2K |
2026 Q1
1 quarter
|
|
213
Diamondrock Hospitality Co
DRH
$2.82B
| $124K | 0.08% |
+10,157
| New | +$111K |
2026 Q2
0 quarters
|
|
214
UP Fintech Holding
TIGR
$727M
| $108K | 0.07% |
+24,600
| New | +$143K |
2026 Q2
0 quarters
|
|
215
Mobileye
MBLY
$5.56B
| $106K | 0.07% |
+11,000
| New | +$98K |
2026 Q2
0 quarters
|
|
216
Patterson-UTI
PTEN
$4.57B
| $97.3K | 0.06% |
+10,600
| New | +$118K |
2026 Q2
0 quarters
|
|
217
Dauch Corp
DCH
$1.1B
| $90K | 0.06% |
+16,600
| New | +$101K |
2026 Q2
0 quarters
|
|
218
AH Realty Trust
AHRT
$455M
| $81.4K | 0.05% |
+11,500
| New | +$73.8K |
2026 Q2
0 quarters
|
|
219
MiMedx Group
MDXG
$571M
| $70.8K | 0.05% |
+18,400
| New | +$67.2K |
2026 Q2
0 quarters
|
|
220
Iovance Biotherapeutics
IOVA
$6.38B
| $63.6K | 0.04% |
+15,300
| New | +$58.1K |
2026 Q2
0 quarters
|
|
221
Ardelyx
ARDX
$795M
| $56.6K | 0.04% |
+11,100
| New | +$67.8K |
2026 Q2
0 quarters
|
|
222
Organogenesis Holdings
ORGO
$128M
| $35.2K | 0.02% |
+14,500
| New | +$35.4K |
2026 Q2
0 quarters
|
|
223
Cerus
CERS
$470M
| $29.4K | 0.02% |
+10,071
| New | +$24.4K |
2026 Q2
0 quarters
|
|
224
AbbVie
ABBV
$505B
| – | – |
-1,177
| Closed | -$256K | – |
|
225
Arbor Realty Trust
ABR
$545M
| – | – |
-53,600
| Closed | -$413K | – |
|
Similar funds
HSM
APW
Bayesian Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Bayesian Capital Management held 328 positions worth $156M, up 91% from $81.9M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Bayesian Capital Management deployed $78.8M of net new capital in Q2 2026, opening 191 new positions and adding to 20 existing holdings. Its largest new stake was Alibaba: 67,999 shares worth $6.53M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Sandisk, an estimated $5.33M trimmed.
- Bayesian Capital Management's largest Q2 2026 buy was Alibaba: 67,999 shares worth $6.53M.
- Bayesian Capital Management added most to Oracle in Q2 2026, an estimated $5.76M increase.
- Bayesian Capital Management's biggest Q2 2026 reduction was Sandisk, cutting an estimated $5.33M.
- Bayesian Capital Management fully exited ExxonMobil in Q2 2026, selling an estimated $2.87M.
- Bayesian Capital Management's ten largest holdings make up 25% of its $156M portfolio in Q2 2026.
- Bayesian Capital Management opened 191 new positions and closed 105 in Q2 2026.
- Bayesian Capital Management's portfolio value rose 91% quarter-over-quarter to $156M.
Based on Bayesian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.